<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01806012</url>
  </required_header>
  <id_info>
    <org_study_id>05022013</org_study_id>
    <nct_id>NCT01806012</nct_id>
  </id_info>
  <brief_title>Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy</brief_title>
  <official_title>Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy: a Randomized, Single-Blinded Study Comparing the Efficacy to the Routine Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ethicon Endo-Surgery (Europe) GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of the EnSeal® instrument for laparoscopic supracervical hysterectomy in a
      randomized, single-blinded comparison to the conventional procedure. The objective of the
      study is to investigate if the use of the Enseal sealing instrument for supracervical
      hysterectomy leads to a shortening of the operation time.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operation time</measure>
    <time_frame>Day 1</time_frame>
    <description>The following times were documented: total operation time; T1 = start of the operation until cornual structures were ready to be dissected; T2 = the time from the first coagulation and cutting of the cornual structures until the complete preparation of each parametrial side directly before cervical detachment; T3 = time needed for the cervical detachment and subsequent steps (morcellation, closure of trocar sites) until the end of the surgical procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>Day 2</time_frame>
    <description>The perioperative blood loss (ΔHb) was calculated using the comparison of the preoperative red blood cells (RBC) versus the RBC on the first post-operative day. The intraoperative blood loss was measured by the suction unit (categories: &lt; 50 ml, 50 - 100 ml, &gt; 100 ml) and by the number of applied blood transfusions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Day 2</time_frame>
    <description>Post-operative pain was documented according to a visual analog pain scale from 1 (no pain) to 10 (maximum pain) during hospital stay.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Indications for Laparoscopic Supracervical Hysterectomy</condition>
  <arm_group>
    <arm_group_label>Enseal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tissue sealing with Enseal device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supracervical hysterectomy using conventional instruments</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Supracervical hysterectomy using conventional instruments</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sealing tissue with the Enseal device</intervention_name>
    <arm_group_label>Enseal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional supracervical hysterectomy</intervention_name>
    <arm_group_label>Supracervical hysterectomy using conventional instruments</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  Indication for supracervical hysterectomy without additional surgical procedures (i.
             e. oophorectomy)

          -  Willingness and capability to comply with all study tests, procedures, and assessment
             tools

          -  Capability of providing informed consent.

        Exclusion Criteria:

          -  History of, or evidence of, gynecologic malignancy within the past five years

          -  Pace maker, internal defibrilator/cardioconverter

          -  Impaired coagulation parameters

          -  Unwillingness to be randomized to treatment

          -  History of median laparotomy

          -  Intraabdominal adhesions

          -  Requirement for open laparoscopy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Women' Clinic Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2013</study_first_submitted>
  <study_first_submitted_qc>March 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2013</study_first_posted>
  <last_update_submitted>March 5, 2013</last_update_submitted>
  <last_update_submitted_qc>March 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Bernhard Kraemer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Supracervical Hysterectomy</keyword>
  <keyword>Leiomyomas</keyword>
  <keyword>Adenomyosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

